CN1064533C - 一种治疗由风寒湿痹引起的红肿热痛复方胶囊 - Google Patents

一种治疗由风寒湿痹引起的红肿热痛复方胶囊 Download PDF

Info

Publication number
CN1064533C
CN1064533C CN96112697A CN96112697A CN1064533C CN 1064533 C CN1064533 C CN 1064533C CN 96112697 A CN96112697 A CN 96112697A CN 96112697 A CN96112697 A CN 96112697A CN 1064533 C CN1064533 C CN 1064533C
Authority
CN
China
Prior art keywords
dampness
wind
cold
compound capsule
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN96112697A
Other languages
English (en)
Other versions
CN1180520A (zh
Inventor
沈春楼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN96112697A priority Critical patent/CN1064533C/zh
Publication of CN1180520A publication Critical patent/CN1180520A/zh
Application granted granted Critical
Publication of CN1064533C publication Critical patent/CN1064533C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

一种治疗由风寒湿痹引起的红肿热痛复方胶囊，由倍他米松、盐酸吡多辛、双氢氯噻嗪、三氨喋呤按比例混合均匀后装入胶囊内所得。本发明对消肿、镇痛有积极的协同效应，疗效显著，毒副作用相互抵消，降至最低服用安全。本发明经四万多例患者服用，显效率100%，无一例有毒副作用反应。

Description

一种治疗由风寒湿痹引起的红肿热痛复方胶囊
本发明涉及一种药物组合物，具体地说是一种治疗由风寒湿痹引起的红肿热痛复方胶囊。
类风湿性关节炎、风湿性关节炎、风湿性多肌痛、肩周炎、痛风、腰腿痛等，中医称之谓风寒湿痹症，此症、特别是发病时多有红、肿、热、痛的表观症状。常用的抗菌素对此无疗效。镇痛剂、利尿剂(消肿)作用单一，若欲既镇痛又消肿，则需同时服用，但须慎用，因为若不懂得药物代谢动力学和药物之间的相互作用，经则影响疗效，重则对人体造成危害。
本发明提供的具有协同效应的复方胶囊旨在对风寒湿痹引起的红、肿、热、痛症引起到既镇痛解热又消肿祛红的治疗效果。
本发明取倍他米松、盐酸吡多辛、双氢氯噻嗪、三氨喋呤按比例复配混合均匀后装入胶囊内即得复方胶囊。所述的比例如下(重量比)
倍他米松、盐酸吡多辛、双氢氯噻嗪、三氨喋呤=1∶50∶62．5∶62．5。
倍他米粉是镇痛剂，但有引起浮肿、向心性肥胖、高血压、低血钾、恶心、呕吐等副作用；双氢氯噻嗪有利尿消肿、降血压以及抗向心性肥胖等作用；三氨喋呤亦是利尿剂有消肿作用，且可排除尿酸，减轻疼痛，同双氢氯噻嗪并用可增强疗效，并可消除倍他米粉和双氢氯噻嗪的排钾副作用；盐酸吡哆辛可抑制恶心、呕吐。
上述四种药按比例复配在一起是申请人在数十年行医实践中总结出来的，对消肿、镇痛有积极的协同效应，疗效显著，毒副作用相互抵消，降至最低。本发明经四万多名患者服用，显效率100％，无一例有毒副作用反应。本发明原料易得(市场有售)，加工方便。
实施例：
取倍他米松4克，盐酸吡多辛200克，双氢氯噻嗪250克，三氨喋呤250克，混合均匀后装入10，000粒胶囊内即得复方胶囊。每粒胶囊内有70．4毫克混合药粉，日服一次，每次一粒。
为适应胶囊机器包装的需要，可以加入辅料如淀粉等一道混合均匀。辅料加入量以胶囊大小为准。以2号胶囊为例，其容积是270毫克，对上述实施例来说应加入1．996千克淀粉同倍他米松、盐酸吡多辛、双氢氯噻嗪、三氨喋呤一道混合均匀后装入10，000粒胶囊内，每粒胶囊内含70．4毫克混合药粉和199．6毫克淀粉。

Claims (1)

1、一种治疗由风寒湿痹引起的红肿热痛复方胶囊，由镇痛剂、利尿剂复配而成，其特征在于：由倍他米松、盐酸吡多辛、双氢氯噻嗪、三氨喋呤依次按1∶50∶62．5∶62．5比例复配后混合均匀装入胶囊内，每粒胶囊内有效成分70．4毫克。
CN96112697A 1996-10-24 1996-10-24 一种治疗由风寒湿痹引起的红肿热痛复方胶囊 Expired - Fee Related CN1064533C (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN96112697A CN1064533C (zh) 1996-10-24 1996-10-24 一种治疗由风寒湿痹引起的红肿热痛复方胶囊

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN96112697A CN1064533C (zh) 1996-10-24 1996-10-24 一种治疗由风寒湿痹引起的红肿热痛复方胶囊

Publications (2)

Publication Number Publication Date
CN1180520A CN1180520A (zh) 1998-05-06
CN1064533C true CN1064533C (zh) 2001-04-18

Family

ID=5121568

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96112697A Expired - Fee Related CN1064533C (zh) 1996-10-24 1996-10-24 一种治疗由风寒湿痹引起的红肿热痛复方胶囊

Country Status (1)

Country Link
CN (1) CN1064533C (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0003828D0 (sv) * 2000-10-20 2000-10-20 Astrazeneca Ab Novel compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
《当代结构药物全集》第一版 1993.1.1 王泽民主编，北京科学技术出版社 *

Also Published As

Publication number Publication date
CN1180520A (zh) 1998-05-06

Similar Documents

Publication Publication Date Title
JP2820319B2 (ja) 急速崩壊性多粒子状錠剤
EP1781277B1 (en) A combination composition comprising ibuprofen and paracetamol
GB2230185A (en) Differential release layered pharmaceutical tablet
KR20030009440A (ko) 조성물
CN100389751C (zh) 含扑热息痛的吞咽片剂
AU2001260212A1 (en) Composition
JP3018160B2 (ja) 月経困難症及び／又は月経前症候群の軽減用薬剤
Veterans Administration Cooperative Study Group on Antihypertensive Agents et al. Captopril: evaluation of low doses, twice-daily doses and the addition of diuretic for the treatment of mild to moderate hypertension
CN101756990B (zh) 用于减肥或治疗高血脂症的药物组合物
EP0100061B1 (en) Pharmaceutical combination composition and associated method
CN107582536B (zh) 一种枸橼酸铋钾口腔粘贴片及其制备方法
CN1064533C (zh) 一种治疗由风寒湿痹引起的红肿热痛复方胶囊
US4526777A (en) Pharmaceutical combination composition and associated method
JP2008056567A (ja) 胃腸疾患の治療又は予防のための医薬
US5035898A (en) Potassium/magnesium supplement
WO2021249286A1 (zh) 一种用于免疫治疗的新药配方及其片剂结构
Adams et al. Ambulatory use of high-dose intravenous morphine for severe pain
JP4153124B2 (ja) 鎮痛剤
US5229132A (en) Non-absorbable gastrointestinal medicament provided for treating the two levels of the digestive tract at the same time
AU749509B2 (en) Use of triclosan for the treatment of helicobacter pylori infections
JPS63132834A (ja) 鎮静剤製剤
JP5070047B2 (ja) 胃腸薬組成物
JP2000229853A (ja) 生理痛改善用組成物
JPH0476972B2 (zh)
CA1283855C (en) Non-absorbable gastrointestinal medicament provided for treating the two levels of the digestive track at the same time

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee